We isolated 8 novel 28-noroleanane-derived spirocyclic triterpenoids with unusual skeleton structures, phlomisone (1), phlomistetraol A (2), phlomistetraol B (3), phlomistetraol C (4), phlomispentaol (5), phlomishexaol A (6), phlomishexaol B (7), and phlomisin (8), from the ethanol extract of Phlomis umbrosa rhizomes. Their structures were elucidated on the basis of spectroscopic methods, including 1D, 2D nuclear magnetic resonance (NMR), high-resolution mass spectrometry (HR-MS), and X-ray analyses. Compounds 1-3, 5, and 7 exhibited positive cytotoxic activities against the carcinoma cell lines Hela and L929 in vitro, and these bioactive data suggested that the C-18 and C-21 positions had oxygenated functions that can improve the activity of the compound.
Phlomis umbrosa TURCZ, one of the plants of the genus Phlomis (Lamiaceae), is a perennial herbaceous plant growing in northern China. Its rhizome has been used in traditional Chinese medicine to reduce swelling and staunch bleeding, and it has anti-inflammatory and detoxification properties. 1, 2) Some iridoids, phenylethanoids, and triterpenes have been previously isolated from the plant. [3] [4] [5] [6] [7] [8] As reported previously, 9) we isolated 4 new nortriterpenoids from the plant. Further studies on the chemical constituents of the rhizomes of this plant enabled us to isolate 8 novel nortriterpenoids (1-8) with a rare skeleton. 10, 11) In this paper, we describe the isolation, structure elucidation, and antitumor activities of compounds 1-8, and for the first time, the skeleton of this type of compound has been confirmed by X-ray analysis.
Results and Discussion
The residue from the 95% ethanol extract of P. umbrosa was partitioned in H 2 O and extracted with petroleum ether (P.E., 60-90°C), EtOAc, and n-BuOH, successively. As the first screening of antitumor bioactivity, the P.E. extract revealed significant antitumor activity in Hela and L929 cell lines. After repeated column chromatography, including silica gel, Toyopearl HW-40C, and semi-preparative HPLC, compounds 1-8 were isolated from the P.E. extract of P. umbrosa.
Phlomisone (1) , which was obtained as colorless needles, revealed an [MϩNa] ϩ ion at m/z 513.3183 [MϩNa] ϩ in the high-resolution positive Fourier transform mass spectrometer (FT-MS) consistent with a molecular formula of C 29 H 46 (Table 3) were similar to those of the known compounds from Phlomis viscosa, 11) compound 1 was assumed to be a pentacyclic nortriterpene.
The partial structure of the pentacyclic E ring was obtained from the heteronuclear single quantum correlation (HSQC) and heteronuclear multiple bond correlation (HMBC) spectra, and combined to the triterpene skeleton by a spiro-carbon atom of d C 50.9 (Fig. 2) . According to the HMBC spectral correlations, the hydroxyl groups deduced from the molecular formula could be located at C-2, C-3, C-18, C-23, and C-24: H-3 (d 4.88) to C-1, C-2, C-5, C-23, and C-24; H 2 -23 to C-3, C-4, C-5, and C-24; and H-18 to C-13 and C-17. Furthermore, in the NOESY spectrum, the proton signal of H-2 correlated with that of H-24 and H-25; that of H-3 correlated with H-24; and that of H-18 correlated with H-27. Thus, the 3 hydroxy groups should be assigned as 2a-, 3a-, and 18b-oriented configurations. The structure of compound 1 was confirmed by X-ray analysis (Fig. 3) , and designated as (17R)-19(18→17)-abeo-2a,3a,18b,23,24-pentahydroxy-28-norolean-12-ene-21-one (Fig. 1) .
HR-FT-MS determined that phlomistetraol A (2) and B (3) had the same molecular formula C 29 H 48 O 4 . The 1 H-NMR spectral data of compounds 2 and 3 (Table 1) revealed the presence of 6 tertiary methyls, 3 oxygenated methines, 1 oxygenated methylene, and 1 vinyl proton signal. The 13 C-NMR spectrum of these compounds revealed 29 carbons (Table 3 ) similar to those of compound 1, except for the absence of a hydroxyl and a ketone group in compounds 2 and 3. The hydroxy groups of compounds 2 and 3 could be located at C-2, C-3, C-18, and C-23 (or C-24) according to the HMBC correlation as follows: H-3 with C-1, C-2, C-5, C-23, and C-24; H 2 -23 with C-3, C-4, C-5, and C-24; and H-18 with C-17 and C-13. In the NOESY spectrum, the correlation of H 3 -24 with H 3 -25 indicated that the hydroxyl group was located at C-23. On the other hand, H-18 correlated with H 3 -27 in compounds 2 and 3, H-3 (d H 3.61, br s) correlated with H-24 in compound 2 and H-3 (d H 3.36, d, Jϭ9.6 Hz) correlated with H-5 and H-23 in compound 3. Accordingly, the configuration of the C-3 and C-18 hydroxy groups had an 3a,18b-orientation in compound 2 and an 3b,18b-orientation in compound 3. Therefore, the structure of phlomistetraol A (2) was determined to be (2a ,3a ,17R,18b )-19(18→17)-abeo-28-norolean-12-ene-2,3,18,23-tetraol and that of phlomistetraol B (3) was assigned as (2a,3b,17R,18b)-19(18→17)-abeo-28-norolean-12-ene-2,3,18,23-tetraol.
Phlomistetraol C (4) had a molecular formula identical to that of 3, i.e., C 29 H 48 O 4 (HR-FT-MS). The NMR spectrum of compound 4 revealed 5 tertiary methyl groups, 2 oxygenated methines, 2 oxygenated methylenes, and a tri-substituted double bond. The 13 C-NMR spectral data of compound 4 was similar to those of compound 3, except for C-18 and C-24 (Table 3 ). The HMBC correlation of H 2 -24 with C-3, C-4, C-5, and C-23 confirmed that the hydroxy group was located at C-24. Phlomispentaol A (5) respectively (Fig. 1) . Phlomishexaol A (6) and B (7) exhibited the same molecular formula of C 29 H 48 O 6 obtained from HR-FT-MS. Both compounds 6 and 7 revealed the presence of 5 methyl signals, 3 oxygenated methines, 2 oxygenated methylenes, and a vinyl proton in the 1 H-NMR spectrum. The 13 C-NMR spectral data of compounds 6 and 7 were similar to those of compound 1, except for the E ring ( 30) . Thus, the configurations of C-16 and C-30 should be b-oriented (Fig. 4) . Thus, the structure of compound 8 was assigned as (2a,3a,16b,17R,30b)-19(18→17)-abeo-16,30-epoxy-28-norolean-12-ene-2,3,23,24,30-pentaol (Fig. 1) .
A plausible biogenetic pathway for above nortriterpenes was proposed on the basis of oleanolic acid isolated from the same plant, Chart 1.
The antitumor activity of compounds 1-8 was determined by using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5- (Table 4) , and these bioactive data suggested that the C-18 and C-21 positions had oxygenated functions that can improve the activity of the compound.
Experimental General Experimental Procedures
The melting point was uncorrected. NMR spectra were run on a Bruker AVANCE 300 instrument ( Extraction and Isolation The powered and dried rhizomes of Phlomis umbrosa (3400 g) was extracted with 95% ethanol (20 lϫ3, 6 h each time) under reflux. The extract was concentrated in vacuo to produce a residue (500 g) suspended in water, which was then partitioned with P.E. (60-90°C), EtOAc, and n-BuOH, successively. The P.E.-partitioned extract (18 g) was chromatographed on a silica gel column, eluted with a solvent gradient system (petroleum ether-EtOAc Phlomisone (1) 
uk).
Procedure for Bioassay We seeded cancer cell lines (Hela and L929) at the concentration of 5ϫ10 4 cells · ml Ϫ1 180 ml in 96-well microplates, and incubated them for 24 h in order to allow cell attachment. The tested compound solutions were added to the cell cultures at proper concentrations, and the cells were incubated (37°C, 5% CO 2 ) for 72 h. Supernatants were then removed using a micropipette, and 100 ml of the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) solution (0.5 mg · ml Ϫ1 ) was then added to each well of 96-well plates and incubated for 4 h. The cell culture medium was removed with a pipette, and the purple formazan crystals were dissolved by adding 100 ml of DMSO to each well. The optical density (OD) was read at a wavelength of 490 nm with a microplate reader. The inhibitory ratio was calculated as follows: IR%ϭ1Ϫ(OD with drug/OD without drug)ϫ100%. 12) 
